Physician profile
Marcus A Averbach
NPI 1568557965
$1,365.86
in general payments reported to CMS, 2019-2025
13 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $44.55 · 2021: $103 · 2022: $395 · 2023: $163 · 2024: $166 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $398.74 | 2022-2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $208.54 | 2019-2025 | Camzyos |
| Pfizer INC. | $162.11 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.60 | 2020-2024 | Jardiance |
| Medtronic, INC. | $129.80 | 2023 | Micra, Linq II |
| Astrazeneca Pharmaceuticals LP | $75.83 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $69.07 | 2021-2023 | Xarelto |
| Ge Healthcare | $34.75 | 2019 | |
| Abiomed | $32.01 | 2022 | |
| Impulse Dynamics (USA) INC. | $31.69 | 2021 | |
| Abbott Laboratories | $29.27 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Esperion Therapeutics, INC. | $27.70 | 2020-2021 | |
| Heartflow, INC. | $26.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Averbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.